Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something? - Top-Institutions - MDSpire

Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

  • By

  • Riccardo Gili

  • Luigi Lorini

  • Davide Smussi

  • Armando Di Bello

  • Paolo Bossi

  • Carlo Resteghini

  • July 1, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Otolaryngology
    • Oncology

  • #2

    Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

    Key Differentiators

    • Otolaryngology
    • Oncology

  • #3

    University of North Carolina (UNC), Chapel Hill
    University of North Carolina (UNC), Chapel Hill

    Chapel Hill, North Carolina

    Key Differentiators

    • Otolaryngology
    • Oncology

  • #4

    Medical University of South Carolina
    Medical University of South Carolina

    Charleston, South Carolina

    Key Differentiators

    • Otolaryngology

  • #5

    Radboud University Medical Center
    Radboud University Medical Center

    Nijmegen, Netherlands

    Key Differentiators

    • Otolaryngology
    • Oncology

Original Source(s)

Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

  • by Riccardo Gili, Luigi Lorini, Davide Smussi, Armando Di Bello, Paolo Bossi, Carlo Resteghini

  • July 1, 2026

Related Content

Efficacy and safety of bupleurum-containing formulas combined with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics

Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics